A dosing regimen for immediate N-acetylcysteine treatment for acute paracetamol overdose

被引:17
作者
Shen, Finna [1 ]
Coulter, Carolyn V. [1 ]
Isbister, Geoffrey K. [2 ,3 ]
Duffull, Stephen B. [1 ]
机构
[1] Univ Otago, Sch Pharm, Dunedin 9054, New Zealand
[2] Calvary Mater Newcastle Hosp, Dept Clin Toxicol, Newcastle, NSW, Australia
[3] Univ Newcastle, Discipline Clin Pharmacol, Newcastle, NSW 2300, Australia
关键词
Liver; Paracetamol; N-acetylcysteine; ADVERSE-REACTIONS; ANAPHYLACTOID REACTIONS; ACETAMINOPHEN; PHARMACOKINETICS; MANAGEMENT;
D O I
10.3109/15563650.2011.604034
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Context. Current treatment of paracetamol (acetaminophen) poisoning involves initiating a 3-phase N-acetylcysteine (NAC) infusion after comparing a plasma concentration, taken >= 4 h post-overdose, to a nomogram. This may result in dosing errors, a delay in treatment, or possibly more adverse effects-due to the use of a high dose rate for the first infusion when treatment is initiated. Objective. Our aim was to investigate a novel dosing regimen for the immediate administration of NAC on admission at a lower infusion rate. Methods. We used a published population pharmacokinetic model of NAC to simulate a scenario where a patient presents to the hospital 2 h post-overdose. The conventional regimen is commenced 6 h post-overdose when the 4-h plasma paracetamol concentration is available. We investigated an NAC infusion using a lower dosing rate initiated immediately on presentation. We determined a dosing rate that gave an area under the curve (AUC) of the concentration-time curve that was the same or greater than that from the conventional regimen on 90% of occasions. Results. Lower dosing rates of NAC initiated immediately resulted in a similar exposure to NAC. An infusion of 110 mg/kg over the first 5 h (22 mg/kg/h) followed by the last two phases of the conventional regimen, or 200 mg/kg over 9 h (22.6 mg/kg/h) followed by the last phase of the conventional regimen could be used. Conclusion. The novel dosing regimen allowed immediate treatment of a patient using a lower dosing rate. This greatly simplifies the current dosing regimen and may reduce NAC adverse effects while ensuring the same amount of NAC is delivered.
引用
收藏
页码:643 / 647
页数:5
相关论文
共 30 条
  • [11] Communicating Critical Test Results: Safe Practice Recommendations
    Hanna, Doris
    Griswold, Paula
    Leape, Lucian L.
    Bates, David W.
    [J]. JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY, 2005, 31 (02) : 68 - 80
  • [12] Acetylcysteine for acetaminophen poisoning
    Heard, Kennon J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (03) : 285 - 292
  • [13] Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning:: A critical review
    Jones, AL
    [J]. JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1998, 36 (04): : 277 - 285
  • [14] The Australasian clinical toxicology investigators collaboration randomized trial of different loading infusion rates of N-acetylcysteine
    Kerr, F
    Dawson, A
    Whyte, IM
    Buckley, N
    Murray, L
    Graudins, A
    Chan, B
    Trudinger, B
    [J]. ANNALS OF EMERGENCY MEDICINE, 2005, 45 (04) : 402 - 408
  • [15] DRUG-THERAPY - ACETAMINOPHEN
    KOCHWESER, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (23) : 1297 - 1300
  • [16] The Effect of Decontamination Procedures on the Pharmacokinetics of Venlafaxine in Overdose
    Kumar, V. V. P.
    Oscarsson, S.
    Friberg, L. E.
    Isbister, G. K.
    Hackett, L. P.
    Duffull, S. B.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (04) : 403 - 410
  • [17] A potentially fatal prescribing error in the treatment of paracetamol poisoning
    Little, M
    Murray, L
    McCoubrie, D
    Daly, FFS
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2005, 183 (10) : 535 - 536
  • [18] ADVERSE REACTIONS TO ACETYLCYSTEINE AND EFFECTS OF OVERDOSE
    MANT, TGK
    TEMPOWSKI, JH
    VOLANS, GN
    TALBOT, JCC
    [J]. BRITISH MEDICAL JOURNAL, 1984, 289 (6439) : 217 - 219
  • [19] PHARMACOKINETICS AND BIOAVAILABILITY OF REDUCED AND OXIDIZED N-ACETYLCYSTEINE
    OLSSON, B
    JOHANSSON, M
    GABRIELSSON, J
    BOLME, P
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 34 (01) : 77 - 82
  • [20] SAFETY OF LATE ACETYLCYSTEINE TREATMENT IN PARACETAMOL POISONING
    PARKER, D
    WHITE, JP
    PATON, D
    ROUTLEDGE, PA
    [J]. HUMAN & EXPERIMENTAL TOXICOLOGY, 1990, 9 (01): : 25 - 27